Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System

被引：17
|
作者：
Bluestein, Sara Beth [1 ]
Yu, Roger [2 ,3 ]
Stone, Cosby, Jr. [1 ]
Phillips, Elizabeth J. [1 ,2 ,4 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulmonary & Crit Care Med, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, 1161 21st Ave S,A2200 MCN, Nashville, TN 37232 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 08期
基金：
美国国家卫生研究院; 英国医学研究理事会;
关键词：
DRESS;
D O I：
10.1016/j.jaip.2021.05.008
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：3208 / +
页数：5
相关论文
共 50 条
  • [1] A Review of Drug Reaction with Eosinophilia and Systemic Symptoms in the FDA Adverse Event Reporting System FAERS)
    Bluestein, Sara
    Yu, Roger
    Stone, Cosby
    Phillips, Elizabeth
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB12 - AB12
  • [2] Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis
    Zhou, Zeyun
    Hultgren, Kyle Emerson
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (03): : 144 - 155
  • [3] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Thomas J. Moore
    Richard L. Morrow
    Colin R. Dormuth
    Barbara Mintzes
    Pharmaceutical Medicine, 2020, 34 : 135 - 140
  • [4] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Moore, Thomas J.
    Morrow, Richard L.
    Dormuth, Colin R.
    Mintzes, Barbara
    PHARMACEUTICAL MEDICINE, 2020, 34 (02) : 135 - 140
  • [5] Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Rahman, Md. Motiur
    Alatawi, Yasser
    Cheng, Ning
    Qian, Jingjing
    Plotkina, Annya V.
    Peissig, Peggy L.
    Berg, Richard L.
    Page, David
    Hansen, Richard A.
    EPILEPSY RESEARCH, 2017, 135 : 71 - 78
  • [6] Adverse events reported to the US Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
    Dores, Graca M.
    Jason, Christopher
    Niu, Manette T.
    Perez-Vilar, Silvia
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1087 - 1100
  • [7] Performance of subgrouped proportional reporting ratios in the US food and drug administration (FDA) adverse event reporting system
    Dauner, Dan
    Zhang, Rui
    Adam, Terrence
    Leal, Eleazar
    Farley, Joel F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 598 - 598
  • [8] Empirical estimation of under-reporting in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Alatawi, Yasser M.
    Hansen, Richard A.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 761 - 767
  • [9] Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system
    Dauner, Daniel G.
    Zhang, Rui
    Adam, Terrence J.
    Leal, Eleazar
    Heitlage, Viviene
    Farley, Joel F.
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (07) : 589 - 597
  • [10] Analysis of Information on Drug Adverse Reactions Using US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Nango, Daisuke
    Sekizuka, Tuyoshi
    Goto, Makoto
    Echizen, Hirotoshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (04): : 341 - 344
12345